Faropenem
Therapeutic agent (verify pharmacological class)
What it is used for
Community-acquired pneumonia, bacterial sinusitis, chronic bronchitis and skin infections. Clinical selection for Faropenem should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Obtain allergy and medication history. Adjust for renal/hepatic impairment, pregnancy, lactation, extremes of age and interacting drugs. Use the lowest effective dose for the shortest appropriate duration. Monitor for expected class adverse effects.
Possible side effects
Shock, pseudoanaphylactic symptoms (e.g. wheezing, breathing problems), dizziness, feeling a need to evacuate the bowel, tinnitus, sweating, flushing of the whole body, vascular edema, hypotension, renal impairment, pseudomembranous colitis, Stevens-Johnson syndrome, Lyell syndrome, pneumonia, pyrexia, cough, hepatic disorders. Agranulocytosis, triated muscle softening, muscular pain, feeling of exhaustion, increase, hypersensitivity reactions, vitamin deficiency, symptoms of vitamin K deficiency, low prothrombin and tendency of hemorrhage. Symptoms of vitamin B-group deficiency. GIT disorders. Burning sensation, headache, dizziness, drowsiness, edema, dryness of the mouth and lips, change in nail color, and a washed-out feeling.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.